🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
7.35
+0.01 (0.14%)
At close: Nov 19, 2026, 4:00 PM EST
7.41
+0.06 (0.82%)
After-hours: Nov 19, 2026, 7:56 PM EST

Kura Oncology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
79.3167.4853.88---
Revenue Growth
-23.76%25.24%----
Cost of Revenue
259.37251.13169.97115.2492.81-
Gross Profit
-180.06-183.65-116.08-115.24-92.81-
Selling, General & Admin
132.69119.9877.1150.5747.0546.54
Research & Development
-----84.72
Operating Expenses
132.69119.9877.1150.5747.05131.26
Operating Income
-312.75-303.63-193.2-165.8-139.87-131.26
Interest Expense
-1.38-1.51-1.62-1.55-0.23-0.41
Interest & Investment Income
12.8518.299.715.35.865.6
EBT Excluding Unusual Items
-331.86-286.86-185.11-162.05-134.23-126.08
Gain (Loss) on Sale of Investments
8.498.4913.149.42-1.61-4.39
Pretax Income
-292.79-278.37-171.97-152.63-135.84-130.47
Income Tax Expense
0.080.32.02---
Net Income
-292.87-278.67-173.98-152.63-135.84-130.47
Net Income to Common
-292.87-278.67-173.98-152.63-135.84-130.47
Net Income Growth
------
Shares Outstanding (Basic)
898886736766
Shares Outstanding (Diluted)
898886736766
Shares Change
1.59%1.76%17.66%9.31%0.96%25.01%
EPS (Basic)
-3.30-3.18-2.02-2.08-2.03-1.97
EPS (Diluted)
-3.30-3.18-2.02-2.08-2.03-1.97
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-89.12-70.7133.85-124.99-110.69-105.7
Free Cash Flow Per Share
-1.00-0.811.55-1.71-1.65-1.59
Gross Margin
-227.02%-272.14%-215.44%---
Operating Margin
-394.32%-449.94%-358.54%---
Profit Margin
-369.26%-412.95%-322.89%---
Free Cash Flow Margin
-112.37%-104.76%248.40%---
EBITDA
-311.3-302.6-192.35-164.96-139.11-130.7
D&A For EBITDA
1.461.030.850.850.760.56
EBIT
-312.75-303.63-193.2-165.8-139.87-131.26
Revenue as Reported
79.3167.4853.88---
Advertising Expenses
-2.8----
SEC Filings: 10-K · 10-Q